Phase Ib Study of Olaparib Plus Weekly Carboplatin and Paclitaxel in Relapsed Ovarian Cancer

NCT01650376 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

UNKNOWN

Status

52

Enrollment

OTHER

Sponsor class

Conditions

Stage III Ovarian Cancer
Stage IV Ovarian Cancer
Uterine Cancer

Interventions

DRUG: Olaparib
DRUG: Carboplatin
DRUG: Paclitaxel

Sponsor

Swedish Medical Center

Collaborators

[object Object]